Research programme: cancer vaccines - Takis
Latest Information Update: 28 Aug 2020
At a glance
- Originator Takis
- Class Cancer vaccines
- Mechanism of Action Immunostimulants; Neoplasm antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Cancer in Italy
- 21 Jul 2016 Early research in Cancer in Italy (unspecified route)